Startups
Veravas™ is transforming laboratory medicine with a first of its kind, patented antibody detection platform to address unmet clinical needs. This innovative technology uses proprietary nano-sized magnetic beads to preanalytically treat patient samples to remove problematic interferences that can cause false results. With a clean sample, IgA, IgG and IgM immunoglobulins can subsequently be captured and measured against any antigen of interest.
This technology will have a profound impact on the performance and speed of development of new serology methods and facilitates the use of saline oral rinse (saliva-based) as an alternative to serum or plasma. Using this technology, Veravas is bringing high value diagnostic tests to market in areas such as infectious disease, cardiovascular, cancer, and neurological diseases that have not been previously possible.
To learn more about our technologies and clinical applications, visit veravas.com
This technology will have a profound impact on the performance and speed of development of new serology methods and facilitates the use of saline oral rinse (saliva-based) as an alternative to serum or plasma. Using this technology, Veravas is bringing high value diagnostic tests to market in areas such as infectious disease, cardiovascular, cancer, and neurological diseases that have not been previously possible.
To learn more about our technologies and clinical applications, visit veravas.com
Overview
Location
United States, Texas, Austin
Employees
11-50
Phone
+1 888-466-4166
Total raised
$4M
Founded date
2017
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 19, 2020 | Veravas raises $4 million in seed funding to transform laboratory medicine | Veravas, a Charleston, South Carolina-based diagnostic startup has raised $4 million in funding from private investors. The financing, which comes through the issuance of convertible notes, will be used to transform laboratory medicine with... |
| Feb 19, 2020 | Veravas Secures $4M in Seed Funding | Veravas, Inc., a Charleston, S.C.-based diagnostic company, raised $4m in funding. Private investors participated in the round through the issuance of convertible notes. The funds are being used to expand research and development staff, bui... |
Reviews 0
FAQ about VERAVAS, Inc.
When was VERAVAS, Inc. founded?
VERAVAS, Inc. was founded in 2017.
How much funding has VERAVAS, Inc. raised?
VERAVAS, Inc. has raised $4M in total across 1 funding round.
What has the press written about VERAVAS, Inc.?
Parsers VC has collected 3 articles mentioning VERAVAS, Inc., among them “Veravas raises $4 million in seed funding to transform laboratory medicine” (Feb 19, 2020) and “Veravas Secures $4M in Seed Funding” (Feb 19, 2020).
Is VERAVAS, Inc. still active?
Yes, VERAVAS, Inc. is active; its latest activity on Parsers VC dates from Oct 19, 2026.